Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Channelopathies and drug discovery in the postgenomic era.

Literature DB >> 21642942

Channelopathies and drug discovery in the postgenomic era.

Dayue Darrel Duan, Tong-hui Ma.

Abstract

Entities: Disease

Mesh：

Substances：
Aquaporins
Ion Channels

Year: 2011 PMID： 21642942 PMCID： PMC4009974 DOI： 10.1038/aps.2011.73

Source DB: PubMed Journal: Acta Pharmacol Sin ISSN： 1671-4083 Impact factor: 6.150

× No keyword cloud information.

37 in total

1. Nanomechanical analysis of insulinoma cells after glucose and capsaicin stimulation using atomic force microscopy.

Authors: Rui-guo Yang; Ning Xi; King Wai-chiu Lai; Bei-hua Zhong; Carmen Kar-man Fung; Chen-geng Qu; Donna H Wang
Journal: Acta Pharmacol Sin Date: 2011-05-30 Impact factor: 6.150

Review 2. Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis.

Authors: Zhi-wei Cai; Jia Liu; Hong-yu Li; David N Sheppard
Journal: Acta Pharmacol Sin Date: 2011-06 Impact factor: 6.150

Review 3. Targeting ryanodine receptors for anti-arrhythmic therapy.

Authors: Mark D McCauley; Xander H T Wehrens
Journal: Acta Pharmacol Sin Date: 2011-06 Impact factor: 6.150

Review 4. Physiological roles and diseases of Tmem16/Anoctamin proteins: are they all chloride channels?

Authors: Charity Duran; H Criss Hartzell
Journal: Acta Pharmacol Sin Date: 2011-06 Impact factor: 6.150

Review 5. Drug discovery for polycystic kidney disease.

Authors: Ying Sun; Hong Zhou; Bao-xue Yang
Journal: Acta Pharmacol Sin Date: 2011-06 Impact factor: 6.150

Review 6. Calcium binding protein-mediated regulation of voltage-gated calcium channels linked to human diseases.

Authors: Nasrin Nejatbakhsh; Zhong-ping Feng
Journal: Acta Pharmacol Sin Date: 2011-06 Impact factor: 6.150

7. Molecular genetic and genetic correlations in sodium channelopathies: lack of founder effect and evidence for a second gene.

Authors: J Wang; J Zhou; S M Todorovic; W G Feero; F Barany; R Conwit; I Hausmanowa-Petrusewicz; A Fidzianska; K Arahata; H B Wessel
Journal: Am J Hum Genet Date: 1993-06 Impact factor: 11.025

Channelopathies and drug discovery in the postgenomic era.

1. Nanomechanical analysis of insulinoma cells after glucose and capsaicin stimulation using atomic force microscopy.

Review 2. Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis.

Review 3. Targeting ryanodine receptors for anti-arrhythmic therapy.

Review 4. Physiological roles and diseases of Tmem16/Anoctamin proteins: are they all chloride channels?

Review 5. Drug discovery for polycystic kidney disease.

Review 6. Calcium binding protein-mediated regulation of voltage-gated calcium channels linked to human diseases.

7. Molecular genetic and genetic correlations in sodium channelopathies: lack of founder effect and evidence for a second gene.

Review 8. Calcium-permeable ion channels involved in glutamate receptor-independent ischemic brain injury.

Review 9. Aquaporin-4: orthogonal array assembly, CNS functions, and role in neuromyelitis optica.

Review 10. TRPM7 in cerebral ischemia and potential target for drug development in stroke.

1. Screening ion-channel ligand interactions with passive pumping in a microfluidic bilayer lipid membrane chip.